Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Simcere Zaiming will receive an upfront payment from AbbVie and is eligible to receive option fees and milestone payments of ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

The initial antibody sequence is then passed through machine learning (ML) models to optimise properties like binding to target ... on millions of Antibody-Antigen pairs in order to identify ...

Researchers have developed a new microscopic method to observe the interactions of therapeutic antibodies with target molecules on tumor cells.

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd., entered an option to license agreement to ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...